|Bid||6.35 x 0|
|Ask||6.37 x 0|
|Day's Range||6.35 - 6.40|
|52 Week Range||3.11 - 6.42|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||3.74|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it has changed its auditors from Ernst & Young LLP ("Former Auditor") to RSM Canada LLP ("Successor Auditor") effective November 23, 2023. At the request of the Company, the Former Auditor resigned as the auditor of the Company effective November 23, 2023 and the board of directors of the Company appointed the Successor Auditor as the Company's auditor effective November 23, 2023, until the next Annual Genera
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") announced today that it has filed, and the Toronto Stock Exchange (the "TSX") has accepted, notice of Cipher's intention to commence a normal course issuer bid ("NCIB") for its common shares (the "Common Shares").
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and nine months ended September 30, 2023.